Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Ziopharm Rebrands As Alaunos Therapeutics

Author: Vandana Singh | January 26, 2022 12:19pm

Ziopharm Ocology Inc (NASDAQ:ZIOP) has rebranded itself and has changed its name to Alaunos Therapeutics Inc.

The Company will trade on NASDAQ under the new ticker symbol "TCRT" to be effective tomorrow.
Along with the name change, the Company amended Phase 1/2 IND to add four additional T-cell receptors (TCRs) to its library, increasing the number of eligible patients for the clinical trial.
Related: Ziopharm Shares Are Trading Lower After Slashing Workforce By Over 50%.
Phase 1/2 TCR-T library trial targeting KRAS, TP53, and EGFR mutations across six solid tumor indications is open for enrollment at Texas' MD Anderson Cancer Center.
Dosing is expected to start in 1H of 2022.
Additionally, to streamline operations, the Company has closed its Boston office. Alaunos will be headquartered in Houston.
Price Action: ZIOP shares are up 1.02% at $0.88 during the market session on the last check Wednesday.

Posted In: ZIOP